Skip to main content
2025 CP Summit Main banner

Challenges and Opportunities in Advancing the Use of AI Technologies Across the Combination Product and Combined Use Lifecycle

Thursday, November 13, 2025
1:40 PM - 2:25 PM East Coast USA Time

    Moderator(s)

  • Ryan Hoshi

    Director, Regulatory Policy and Intelligence
    AbbVie, Inc.

    • Speaker(s)

  • XH

    Xia Huang

    Project Manager for CE Certification of Medical Devices
    DEKRA

  • MiRa Jacobs

    Division Director, Digital Health Policy, Digital Health Center of Excellence, Center for Devices and Radiological Health (CDRH)
    FDA (Virtual)

  • Christina Kuhn

    Special Counsel
    Covington & Burling

There are growing opportunities to leverage the use of AI technologies across the combination product lifecycle from nonclinical and clinical development to post-market surveillance for enhancing safety, efficacy, and quality. However, stakeholders are challenged with understanding emerging global regulatory frameworks on the use of AI and ensuring that AI models are developed responsibly. This session will explore industry and health authority use cases and perspectives on the safe and responsible adoption of AI technologies in the combination product lifecycle.